Cell Signaling

15  articles.  
* There may be some overlapped articles listed due to the difference of format.

  1. Anhao Liu, Mikihito Hayashi, Yujin Ohsugi, Sayaka Katagiri, Shizuo Akira, Takanori Iwata, Tomoki Nakashima: The IL-33/ST2 axis is protective against acute inflammation during the course of periodontitis. Nat Commun. 2024.03; 15 (1): 2707. ( PubMed , DOI )

  1. Yu Yamashita, Mikihito Hayashi, Mitsuru Saito, Tomoki Nakashima: Osteoblast lineage cells-derived Sema3A regulates bone homeostasis independently of androgens Endocrinology. 2022.08; ( PubMed , DOI )

  1. Fumiyuki Sasaki, Mikihito Hayashi, Takehito Ono, Tomoki Nakashima: The regulation of RANKL by mechanical force. J Bone Miner Metab. 2021.01; 39 (1): 34-44. ( PubMed , DOI )

  1. Nasir K Bashiruddin, Mikihito Hayashi, Masanobu Nagano, Yan Wu, Yukiko Matsunaga, Junichi Takagi, Tomoki Nakashima, Hiroaki Suga: Development of cyclic peptides with potent in vivo osteogenic activity through RaPID-based affinity maturation. Proc Natl Acad Sci U S A. 2020.12; 117 (49): 31070-31077. ( PubMed , DOI )

  2. Yosuke Tsuchiya, Mikihito Hayashi, Katashi Nagamatsu, Takehito Ono, Masaki Kamakura, Takanori Iwata, Tomoki Nakashima: The key royal jelly component 10-hydroxy-2-decenoic acid protects against bone loss by inhibiting NF-κB signaling downstream of FFAR4. J. Biol. Chem.. 2020.07; ( PubMed , DOI )

  3. Yoshitaka Kameo, Yuki Miya, Mikihito Hayashi, Tomoki Nakashima, Taiji Adachi: In silico experiments of bone remodeling explore metabolic diseases andtheir drug treatment. Science Advances. 2020.03; 6 (10): eaax0938.

  4. Takehito Ono, Mikihito Hayashi, Fumiyuki Sasaki, Tomoki Nakashima: RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen. 2020.02; 40 2. ( PubMed , DOI )

  5. Fumiyuki Sasaki, Mikihito Hayashi, Yuki Mouri, Satoshi Nakamura, Taiji Adachi, Tomoki Nakashima: Mechanotransduction via the Piezo1-Akt pathway underlies Sost suppression in osteocytes. Biochemical and Biophysical Research Communications. 2020.01; 521 (3): 806-813.

  1. Mikihito Hayashi, Tomoki Nakashima, Noriko Yoshimura, Kazuo Okamoto, Sakae Tanaka, Hiroshi Takayanagi.: Osteocyte Sema3A orchestrates estrogen action and counteracts bone aging. Cell Metabolism. 2019.03; 29 627-637.

  1. Yusoon Kim, Mikihito Hayashi, Takehito Ono, Tetsuya Yoda, Hiroshi Takayanagi, Tomoki Nakashima.: Suppression of hematopoietic cell kinase ameliorates the bone destruction associated with inflammation. Modern Rheumatology. 2018.11;

  1. Y Fukushima-Nakayama, Takehito Ono, M Hayashi, M Inoue, H Wake, Takashi Ono, T Nakashima: Reduced Mastication Impairs Memory Function. J. Dent. Res.. 2017.08; 96 (9): 1058-1066. ( PubMed , DOI )

  2. Ayumi Shoji-Matsunaga, Takehito Ono, Mikihito Hayashi, Hiroshi Takayanagi, Keiji Moriyama, Tomoki Nakashima: Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression. Sci Rep. 2017.08; 7 (1): 8753. ( PubMed , DOI )

  1. Mikihito Hayashi, Tomoki Nakashima, Masahiko Taniguchi, Tatsuhiko Kodama, Atsushi Kumanogoh, Hiroshi Takayanagi: Osteoprotection by semaphorin 3A. Nature. 2012.05; 485 (7396): 69-74. ( PubMed , DOI )

  1. Tomoki Nakashima, Mikihito Hayashi, Takanobu Fukunaga, Kosaku Kurata, Masatsugu Oh-Hora, Jian Q Feng, Lynda F Bonewald, Tatsuhiko Kodama, Anton Wutz, Erwin F Wagner, Josef M Penninger, Hiroshi Takayanagi: Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med.. 2011.10; 17 (10): 1231-1234. ( PubMed , DOI )

  1. Semaphorin and osteoporosis 2016.10; 26 (10): 1419-1427. ( PubMed , DOI )

To the head of this page.▲